Maybe news??? Would that be good news or bad news?
Will
Maybe news??? Would that be good news or bad news?
Will it be Dr. Recknors “very soon” news? Will it be accompanied by a partnership or not?
So many scenarios to contemplate. Does anyone have a grip on what’s going to happen? Is there a blooming happening in April Shelly? Will this 10Q be released after market closes? Most likely.
The show will be Tuesday for up or down on Stock Price. Tomorrow brings much speculation about the 10Q. The adjustment to the price is definitely Tuesday. The only question is will it go up or go down and how much…
I have a dream… lets say that there is a PR before market opens Monday telling us that we have a partner for NAFLD/NASH with the best results in a phase 2 trial that has ever happened so far in pharmaceutical history of Nash trials. That partnership is with a well known company we have dealt with before. One that wants to get into the pharmaceutical business and not just manufacture.
Wouldn’t this be a big welcomed surprise if it was Samsung and they become our rich big brother and only want a partnership for just NAFLD/NASH. The news of partnership ends up repairing our relationship with our manufacturing buddy and Samsung gives us the upfront monies to accomplish a nice phase 3 trial with all the bells and whistles of biopsies and all 4 of the trial markers we used in the phase 2 trial. Enough up front milestone money that dilution is not needed the rest of the year. Our only focus becomes the new Nash trial. The biopsies before trial and after of the liver being the golden goose egg we need to acquire for the FDA to get our BLA for what could be the best and only drug ever to show a reversal of the fibrosis of the liver.
I want to dream tonight in bed… about… it’s almost time to start calculating the worlds population of over 9 billion with 30% having NAFLD and 3-10% having Nash. Let’s see how much that adds up to with weekly injections of Leronlimab for over 3 Billion people… hmmm. Calculators just don’t carry enough spaces for calculations like this. Show me another drug in the world that would touch 10-30% of the worlds population… there isn’t one… there is not even a drug that comes close to 1% of the worlds population. ohhhh… this is what dreams are made of…
Then we spend all afternoon and evening dissecting how many people will be needed in a phase 3 BTD confirmation trial, how long this will take and will they apply for a the BTD to move the pace up on revenue and then… When will you buy your first toy and or maybe buy Putin’s summer Cottage on the Black Sea. Naw… who could afford a 2 billion dollar tiny cottage with its own inside professional hockey arena.
Then I wake up and none of it’s true as it was just a dream and we start speculating anyways because there is no information of importance in the 10Q… and Recknor can’t release any information just yet. NDA’s are being respected and we wait patiently like we have for the last 3 months… damn… that was a nightmare not a dream… but there is hope a dream can happen… did I say that right??? There is hope a dream can happen. I will go to sleep tonight hoping for a dream like I hoped for and not a nightmare. The ride has been hard and long enough… we need some really great news this week. Let’s hope! The world needs our hope!
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
It's rare that infrastructure projects generate excitement, but U.S. GoldMining's nod to the West Susitna Access Project has the potential to shake things up in Alaska. On August 27, 2026, AIDEA greenlit a bold $25 million investment for geotechnical and engineering work, promising to bridge the Whistler Project with Southcentral Alaska's transport grid. Folks, we're...
Continue Reading
There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...
Continue Reading
When ASUS throws its hat in the ring, you know it's going for the knockout. At IFA 2026, they're swinging for the fences with their new ProArt lineup—powered by NVIDIA RTX Spark. We're talking serious AI muscle here, up to 1 petaflop worth! What Makes This Lineup a Game Changer? The ProArt series, comprising of the P16 and P14 laptops, alongside the GR1X mini PC, is a...
Continue Reading
Arrow's Halloween Play: Enter the "Light the Fright" Ever seen DIY weaponry double as a Halloween trick? Arrow Tool Group's stepping into spooky season with their "Light the Fright" Halloween Giveaway, bringing in DIY dynamo Serena Appiah to showcase their T301 Multi-Tacker Staple Gun. Now, this isn't just another run-of-the-mill promo. They're handing over an arsenal...
Continue Reading
Big Leagues in Tax: Holly Paz Joins alliant Tax is one of those fields that's not for the faint of heart. It's complex, ever-changing, and can make or break businesses. Enter Holly Paz, once at the helm of the IRS's Large Business & International Division, now bringing her vast experience to alliant. Paz is a bona fide heavyweight in tax administration, and her arrival at...
Continue Reading
Nauticus Robotics Hits New Stride with ROV Deployments Some days, you're paddling like hell to stay afloat in this market. But for Nauticus Robotics, marking progress amidst turbulent waters, their recent announcement feels like catching a favorable current. Both of Nauticus’ Comanche ROV systems have been deployed for commercial projects, enhancing their third quarter...
Continue Reading
Unrest Brewing in Riverside: Amazon's Labor Showdown September 1, 2026, marks a potentially seismic shift in labor disputes within one of America's corporate titans—Amazon. Picture this: workers slinging on their boots, not for a day of hauling goods in Amazon's largest U.S. warehouse, DJT6, but for a united stand outside its gates. Who's at the helm? The Teamsters...
Continue Reading
Roomba Max 875 Combo: Setting a New Standard Alright, folks, iRobot's at it again—unleashing what they tout as their beefiest cleaner to date, the Roomba Max 875 Combo Robot. It's a name that might twist your tongue, and this technological titan's feature list is equally complex. You know the routine with these fancy gadget launches: big promises, shiny features, but...
Continue Reading
Tackling the Two-Speed Transition It's like this: clean energy's racing ahead but dragging a stubborn mule behind. Sure, we saw solar and EVs hustle past every forecast last year, with a record-breaking $2.1 trillion in investment. But, ever notice how despite all this, emissions aren't exactly nose-diving? Global CO2's hovering like a bad cold, thanks to the unending...
Continue Reading
Understanding the Unique Real Estate Landscape in Show Low When it comes to selling a home in Show Low, Arizona, price ain't just a number thrown on a sheet. It’s more like a dance—where setting the right rhythm can lead to interested home-buying partners. Real estate experts Josh Meacham and Anthony Marangon of HomeSmart Pros break down the moves in their...
Continue Reading
Top 5 Most Recently Viewed Articles
Hansei Solutions Welcomes New COO Nick Rogers Hansei Solutions, known for its expertise in revenue cycle management (RCM) in the behavioral health sector, has appointed Nick Rogers as Chief Operating Officer (COO). This strategic decision aims to boost operational growth and technological advancement within the company. Nick Rogers: A Leader with Proven Expertise With...
Continue Reading
The Next Wave in Financial Planning So, here we are, standing at the crossroads of financial planning's future. We're seeing not only how the next generation is shaping up but also the very terms they're setting for employers. FP Transitions just dropped some revealing research on us. It's about time someone asked these young hotshots what they really want. And surprise,...
Continue Reading
Important Investor Information for United Parcel Service As a shareholder in United Parcel Service, Inc. (NYSE: UPS), you may want to stay abreast of recent developments that could impact your investments. It's essential to understand what steps you can take if you have been affected by company actions in the past. Understanding Your Rights as a Shareholder Have you owned...
Continue Reading
Boeing's Nod to SeAH: A Big Win in Aerospace SeAH Aerospace & Defense just bagged one of those shiny recognitions from Boeing, the Supplier Production Partner Award. It's akin to the Oscars in aerospace supply chains, a pat on the back for doing things right. Boeing's not one to dish these out casually, so it's no garden-variety endorsement. This moves SeAH firmly into...
Continue Reading
GH Research Announces Key Symposium Participation GH Research PLC (NASDAQ: GHRS), a pioneering biopharmaceutical company focused on innovative depression treatments, has been selected to present significant findings at a prominent conference. The upcoming 38th Annual European College of Neuropsychopharmacology Congress (ECNP) will take place from October 11 to 14, where...
Continue Reading